Log in

NASDAQ:TMDITitan Medical Stock Price, Forecast & News

$0.21
-0.04 (-15.84 %)
(As of 04/5/2020 01:43 PM ET)
Add
Compare
Today's Range
$0.20
Now: $0.21
$0.23
50-Day Range
$0.15
MA: $0.30
$0.43
52-Week Range
$0.12
Now: $0.21
$3.14
Volume736,318 shs
Average Volume4.09 million shs
Market Capitalization$11.02 million
P/E RatioN/A
Dividend YieldN/A
Beta3.5
Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the SPORT Surgical System, a single-port robotic surgical system that comprises a surgeon-controlled patient cart, which includes a 3D vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The SPORT Surgical System enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and general abdominal indications. Titan Medical Inc. is headquartered in Toronto, Canada.
Read More
Titan Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.15 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TMDI
CUSIPN/A
CIKN/A
Phone416-548-7522

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.19 per share

Profitability

Net Income$-22,640,000.00

Miscellaneous

Employees9
Market Cap$11.02 million
Next Earnings Date5/12/2020 (Estimated)
OptionableNot Optionable

Receive TMDI News and Ratings via Email

Sign-up to receive the latest news and ratings for TMDI and its competitors with MarketBeat's FREE daily newsletter.


Titan Medical (NASDAQ:TMDI) Frequently Asked Questions

How has Titan Medical's stock been impacted by COVID-19 (Coronavirus)?

Titan Medical's stock was trading at $0.20 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TMDI stock has increased by 6.3% and is now trading at $0.2126. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Titan Medical?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Titan Medical in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Titan Medical.

When is Titan Medical's next earnings date?

Titan Medical is scheduled to release its next quarterly earnings announcement on Tuesday, May 12th 2020. View our earnings forecast for Titan Medical.

What price target have analysts set for TMDI?

3 brokers have issued 12 month price objectives for Titan Medical's stock. Their forecasts range from $1.00 to $1.50. On average, they anticipate Titan Medical's stock price to reach $1.25 in the next twelve months. This suggests a possible upside of 488.0% from the stock's current price. View analysts' price targets for Titan Medical.

Has Titan Medical been receiving favorable news coverage?

News coverage about TMDI stock has trended very negative recently, InfoTrie reports. InfoTrie ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Titan Medical earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutTitan Medical.

Are investors shorting Titan Medical?

Titan Medical saw a increase in short interest during the month of March. As of March 13th, there was short interest totaling 670,600 shares, an increase of 17.6% from the February 27th total of 570,400 shares. Based on an average daily trading volume, of 481,900 shares, the days-to-cover ratio is presently 1.4 days. Currently, 1.7% of the company's shares are sold short. View Titan Medical's Current Options Chain.

Who are some of Titan Medical's key competitors?

What other stocks do shareholders of Titan Medical own?

Who are Titan Medical's key executives?

Titan Medical's management team includes the following people:
  • Mr. David J. McNally, Pres, CEO & Director (Age 57)
  • Mr. Stephen D. Randall, CFO, Sec. & Director
  • Dr. Perry A. Genova, Sr. VP of R&D
  • Mr. Curtis R. Jensen, VP of Quality & Regulatory Affairs
  • Mr. Sachin A. Sankholkar, VP of Marketing

What is Titan Medical's stock symbol?

Titan Medical trades on the NASDAQ under the ticker symbol "TMDI."

How do I buy shares of Titan Medical?

Shares of TMDI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Titan Medical's stock price today?

One share of TMDI stock can currently be purchased for approximately $0.21.

How big of a company is Titan Medical?

Titan Medical has a market capitalization of $11.02 million. The company earns $-22,640,000.00 in net income (profit) each year or ($1.95) on an earnings per share basis. Titan Medical employs 9 workers across the globe. View additional information about Titan Medical.

What is Titan Medical's official website?

The official website for Titan Medical is http://www.titanmedicalinc.com/.

How can I contact Titan Medical?

Titan Medical's mailing address is 170 UNIVERSITY AVENUE, TORONTO A6, M5H 3B3. The company can be reached via phone at 416-548-7522.

This page was last updated on 4/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel